2023

All Categories

2023

Date Title Document
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis Date 12/21/23 Title Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis Download pdf
DUOBRII™ lotion to treat moderate to severe plaque psoriasis now available through Quebec’s public drug plan Date 12/18/23 Title DUOBRII™ lotion to treat moderate to severe plaque psoriasis now available through Quebec’s public drug plan Download pdf
Salix In Collaboration With The U.S. Pain Foundation And The International Foundation For Gastrointestinal Disorders Establish The Inaugural Opioid- Induced Constipation (Oic) Awareness Day Date 12/05/23 Title Salix In Collaboration With The U.S. Pain Foundation And The International Foundation For Gastrointestinal Disorders Establish The Inaugural Opioid- Induced Constipation (Oic) Awareness Day Download pdf
The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis Date 11/10/23 Title The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis Download pdf
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD) Date 11/08/23 Title As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD) Download pdf
Bausch Health Announces Third-Quarter 2023 Results Date 11/02/23 Title Bausch Health Announces Third-Quarter 2023 Results Download pdf
U.S. District Court Dismisses Norwich’s Lawsuit Against the FDA Date 11/01/23 Title U.S. District Court Dismisses Norwich’s Lawsuit Against the FDA Download pdf
Bausch Health Unveils "Looking Forward" – A New DTC Television Campaign for Seasonal Affective Disorder (SAD) Date 10/25/23 Title Bausch Health Unveils "Looking Forward" – A New DTC Television Campaign for Seasonal Affective Disorder (SAD) Download pdf
FDA Approves CabtreoTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel For The Treatment Of Acne Vulgaris In Patients Twelve Years Of Age And Older Date 10/20/23 Title FDA Approves CabtreoTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel For The Treatment Of Acne Vulgaris In Patients Twelve Years Of Age And Older Download pdf
New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence Date 10/17/23 Title New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence Download pdf
Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2 Date 10/12/23 Title Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2 Download pdf
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase In Chronic Liver Disease And Cirrhosis-related Deaths Marking These As Ninth Leading Cause Of Death In U.S. Date 10/10/23 Title Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase In Chronic Liver Disease And Cirrhosis-related Deaths Marking These As Ninth Leading Cause Of Death In U.S. Download pdf
Salix Pharmaceuticals partners with Bellamy Young Date 10/04/23 Title Salix Pharmaceuticals partners with Bellamy Young Download pdf
Bausch Health’s Bausch + Lomb Announces Completion of the Acquisition of XIIDRA® Date 09/29/23 Title Bausch Health’s Bausch + Lomb Announces Completion of the Acquisition of XIIDRA® Download pdf
League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease Date 09/21/23 Title League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease Download pdf
Bausch Health announces CFO Transition Plan Date 09/18/23 Title Bausch Health announces CFO Transition Plan Download pdf
New Bausch Health treatment PrUCERIS® (budesonide) aerosol foam now available across Canada to treat mild to moderate distal ulcerative colitis in adults Date 09/12/23 Title New Bausch Health treatment PrUCERIS® (budesonide) aerosol foam now available across Canada to treat mild to moderate distal ulcerative colitis in adults Download pdf
Bausch Health’s Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA® Date 09/11/23 Title Bausch Health’s Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA® Download pdf
Bausch Health’s Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA® Date 09/06/23 Title Bausch Health’s Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA® Download pdf
Bausch Health Announces Second-Quarter 2023 Results, other key updates from the Quarter, and raises Full-Year 2023 Revenue Outlook Date 08/03/23 Title Bausch Health Announces Second-Quarter 2023 Results, other key updates from the Quarter, and raises Full-Year 2023 Revenue Outlook Download pdf
Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients Date 07/27/23 Title Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients Download pdf
Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3 Date 07/13/23 Title Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3 Download pdf
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners Date 07/11/23 Title Salix Announces 2023 Gastrointestinal Health Scholars Program Winners Download pdf
OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services® at the American Dental Hygienists’ Association (ADHA®) Annual Conference Date 07/07/23 Title OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services® at the American Dental Hygienists’ Association (ADHA®) Annual Conference Download pdf
Bausch Health Enters Into $600 Million Financing Facility With KKR Date 07/07/23 Title Bausch Health Enters Into $600 Million Financing Facility With KKR Download pdf
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA® Date 06/30/23 Title Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA® Download pdf
Salix to Present Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2023 Date 06/19/23 Title Salix to Present Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2023 Download PDF
Bausch Health Responds to Norwich’s ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration Date 06/06/23 Title Bausch Health Responds to Norwich’s ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration Download PDF
OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease Date 05/31/23 Title OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease Download pdf
New Clinical Study Suggests the Use of OraPharma’s ARESTIN® (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis Date 05/18/23 Title New Clinical Study Suggests the Use of OraPharma’s ARESTIN® (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis Download pdf
U.S. District Court Upholds Final Judgment for XIFAXAN® 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Date 05/17/23 Title U.S. District Court Upholds Final Judgment for XIFAXAN® 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Download pdf
Bausch Health Announces 2023 Annual Meeting of Shareholder Results Date 05/17/23 Title Bausch Health Announces 2023 Annual Meeting of Shareholder Results Download pdf
Bausch Health Observes Mental Health Awareness Month Date 05/10/23 Title Bausch Health Observes Mental Health Awareness Month Download pdf
Salix Pharmaceuticals To Deliver Podium Presentation At Digestive Disease Week® 2023 Date 05/08/23 Title Salix Pharmaceuticals To Deliver Podium Presentation At Digestive Disease Week® 2023 Download pdf
Bausch Health Announces First-Quarter 2023 Results Date 05/04/23 Title Bausch Health Announces First-Quarter 2023 Results Download pdf
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel Date 05/01/23 Title Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel Download pdf
Salix Partners with the Colorectal Cancer Alliance on Community Screening Program Date 04/24/23 Title Salix Partners with the Colorectal Cancer Alliance on Community Screening Program Download pdf
Bausch Health to Announce First-Quarter 2023 Results on May 4 Date 04/13/23 Title Bausch Health to Announce First-Quarter 2023 Results on May 4 Download pdf
More than half of IBS patients surveyed report waiting more than one year before discussing IBS symptoms with their healthcare provider Date 04/04/23 Title More than half of IBS patients surveyed report waiting more than one year before discussing IBS symptoms with their healthcare provider Download pdf
Bausch Health Announces Changes to its Board of Directors Date 03/01/23 Title Bausch Health Announces Changes to its Board of Directors Download PDF
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results Date 02/23/23 Title Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results Download pdf
Salix Announces 2023 Gastrointestinal Health Scholars Program Date 02/13/23 Title Salix Announces 2023 Gastrointestinal Health Scholars Program Download PDF
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23 Date 02/01/23 Title Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23 Download PDF
Powered by Sitecore